primary laryngeal lymphangioma
ORPHA: 1379261 Treatment Available
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| sirolimus Orphan | Oral tablet 0.5mg/1mg/2mg, oral solution 1mg/mL | FDA Approved, EMA Approved | 13 | 5d |
Classification & Codes
Orphanet Code
ORPHA:137926primary laryngeal lymphangioma
| Orphanet | ORPHA:137926 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO